This trial is testing whether mindfulness-based interventions can help chronic pain patients who are taking opioids by reducing their pain and how much opioids they need.
2 Primary · 4 Secondary · Reporting Duration: At baseline and posttreatment, approximately 1.5 months
Active Control
Experimental Treatment
148 Total Participants · 2 Treatment Groups
Primary Treatment: Mindful Interoceptive Mapping · No Placebo Group · N/A
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Utah | 100.0% |
18 - 65 | 100.0% |
Did not meet criteria | 100.0% |